UnknownNCT02127463
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
PHASE2 · PHASE3 · 60 planned enrolment
- Countries listed
- 1
- Registry update
- April 30, 2014
immortal.lifeTrial registrations containing the exact intervention label MC-1101 Vehicle.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · PHASE3 · 60 planned enrolment
PHASE2 · PHASE3 · 22 planned enrolment